Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Texas
| Provider | Medicare | Services |
|---|---|---|
| Crown Imaging, Llc | $1,891.49 | 199 |
| Menick, Barry M.D. | $1,862.55 | 169 |
| Altmeyer, Wilson MD | $1,906.48 | 82 |
| Health Imaging Partners, Llc | $1,865.44 | 72 |
| Ara/St. David's Imaging, Lp | $1,961.83 | 64 |
| Khandheria, Paras M.D. | $1,857.43 | 51 |
| Garcia, Rodolfo M.D. | $2,198.54 | 47 |
| Xie, Yun MD | $1,418.13 | 43 |
| Spiridonov, Stanislav M.D. | $1,956.44 | 30 |
| Chandler, Robert MD | $1,375.54 | 29 |
| Cervantes, Margo M.D. | $1,400.71 | 27 |
| Health Imaging Partners, Llc | $1,974.11 | 26 |
| Auber, Andrew M.D. | $1,871.59 | 25 |
| Vanexan, Kenneth MD | $1,838.22 | 18 |
| Leake, James | $1,952.37 | 18 |
| Excel Diagnostics Ltd | $1,399.75 | 17 |
Texas Pricing in Context
In Texas, CPT code A9584 (Iodine 1-123 Ioflupane, Diagnostic, Per Study Dose, Up To 5 Millicuries) carries an average Medicare payment of $1,841.80 — 11% below the national benchmark of $2,070.16. 39 providers across the state submitted claims for this procedure in 2023, performing 1.0K total services. Individual payments in TX ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Texas is $4,111.10, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Texas sits below the national Medicare average, commercial rates in the state may also run lower than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Medical Supplies procedures, the estimated commercial insurance price in Texas lands near $5,319.15, with self-pay cash prices typically around $2,865.06. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Iodine 1-123 Ioflupane, Diagnostic, Per Study Dose, Up To 5 Millicuries cost in Texas?
The average Medicare payment for Iodine 1-123 Ioflupane, Diagnostic, Per Study Dose, Up To 5 Millicuries in Texas is $1,841.80, which is 11% below the national average of $2,070.16. Providers in TX typically bill $4,111.10 for this procedure.
What does Iodine 1-123 Ioflupane, Diagnostic, Per Study Dose, Up To 5 Millicuries cost with insurance in Texas?
With commercial insurance in Texas, Iodine 1-123 Ioflupane, Diagnostic, Per Study Dose, Up To 5 Millicuries costs an estimated $5,319.15. Without insurance, the estimated cash price is $2,865.06. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Iodine 1-123 Ioflupane, Diagnostic, Per Study Dose, Up To 5 Millicuries in Texas?
39 providers in Texas billed Medicare for Iodine 1-123 Ioflupane, Diagnostic, Per Study Dose, Up To 5 Millicuries in 2023, performing 1.0K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Iodine 1-123 Ioflupane, Diagnostic, Per Study Dose, Up To 5 Millicuries cheaper in Texas than the national average?
Yes — Iodine 1-123 Ioflupane, Diagnostic, Per Study Dose, Up To 5 Millicuries costs 11% below the national average in Texas. The state average Medicare payment is $1,841.80 compared to $2,070.16 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.